Biology & biomedicine Technological offers
Researchers develop an accommodative lens to imitate the crystalline in order to correct the presbyopia
- Details
- Category: Technological offers
-
22 Oct 2019
Scientists at the Instituto de Óptica have developed a new intraocular lens, which changes shape to focus on distant and near objects in order to imitate the crystalline lens function. It is the result of the Presbyopia project, funded by the European Research Council (ERC).
Low cost and reusable wearable sensors
- Details
- Category: Technological offers
-
18 Jun 2019
Scientists at the CSIC have developed new portable and non-invasive sensors for monitoring biomarkers such as glucose, lactate or alcohol. They are based on wireless electro chromic and electrochemical sensors, and they can be used to detect metabolites in biological fluids, either human fluids (sweat, urine…) or in fluids derived from food products (e.g., leaking).
Preclinical trial with efavirenz for the treatment of Niemann-Pick C disease
- Details
- Category: Technological offers
-
05 Apr 2019
A team of scientists from the Centro de Biología Molecular Severo Ochoa (CMBSO-CSIC) has developed a new treatment for the Niemann-Pick disease type C (NPC) based on the drug efavirenz. The study is at the preclinical stage.
Modulating compounds of KChIP2 and its use for the treatment of cardiovascular pathologies
- Details
- Category: Technological offers
-
18 Jun 2019
CSIC and UAM have developed compounds that positively modulate protein-protein interactions that involve KChIP2protein. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement.
A smart patch enables easy diagnosis of cystic fibrosis
- Details
- Category: Technological offers
-
27 Feb 2019
A team led by CSIC scientists at the Institut de Microelectrònica de Barcelona (IMB-CNM), has developed a smart device based on a paper battery, which will make easier diagnosis of cystic fibrosis possible. This small device looks like a plaster and includes the sensing device and the energy source. Now, the scientific team is working for the clinical validation and transferring the device to the market.
